Andere talen Aprogen Medicines Inc.

Aandelen

A007460

KR7007460009

slotkoers Korea S.E. Andere beurzen 00:00:00 30-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1.579 ^KRW	+6,33%		+8,75%	+64,48%

19/03	Aprogen Medicines Inc. rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI
2023	Aprogen Medicines Inc. rapporteert resultaten voor het derde kwartaal en de negen maanden eindigend op 30 september 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Aprogen Medicines Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	19/03
Aprogen Healthcare & Games Inc. announced that it expects to receive KRW 35.00000038 billion in funding from Aprogen Medicines Inc., G-Baise Inc.	11/12
Aprogen Medicines Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Aprogen Medicines Inc. announced that it has received KRW 5.5 billion in funding	23-10-23
Aprogen Medicines Inc. announced that it expects to receive KRW 5.5 billion in funding	13-10-23
Aprogen Medicines Inc. announced that it has received KRW 70 billion in funding	14-09-23
Aprogen Medicines Inc. announced that it expects to receive KRW 70 billion in funding	08-09-23
Aprogen Medicines Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14-08-23
Aprogen Medicines Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15-05-23
Aprogen Biologics Inc. announced that it has received KRW 40.0000005 billion in funding from Aprogen Medicines Inc.	12-04-23
Aprogen Medicines Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14-11-22
Aprogen Biologics Inc. announced that it expects to receive KRW 50 billion in funding from Aprogen Medicines Inc.	04-10-22
Aprogen Medicines Inc. completed the acquisition of remaining unknown stake in Aprogen, Inc.	18-07-22
Aprogen Medicines Inc. signed a merger contract to acquire remaining unknown stake in Aprogen, Inc.	18-11-21
Aprogen Medicines Inc. announced that it expects to receive KRW 105 billion in funding from Korea Fixed Income Investment Advisory Co., Ltd., Aprogen pharmaceuticals,Inc., Aprogen Healthcare & Games Inc.	16-09-21
Aprogen KIC Inc. announced that it has received KRW 20 billion in funding from Korea Bond Investment Advisory Co., Ltd.	21-01-21
Aprogen KIC Inc. cancelled the acquisition of additional 5.6% stake in Aprogen pharmaceuticals,Inc..	14-01-21
Aprogen KIC Inc. announced that it expects to receive KRW 20 billion in funding from Korea Bond Investment Advisory Co., Ltd.	07-01-21
Aprogen KIC Inc. announced that it has received KRW 50 billion in funding from Wooridul Huebrain Ltd. and another investor	13-10-20
Aprogen KIC Inc. announced that it expects to receive KRW 50 billion in funding from Wooridul Huebrain Ltd. and another investor	12-10-20

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Aprogen Medicines Inc.

Aandelen

A007460

KR7007460009

Andere talen

Filters